Houman Ashrafian
Chief Tech/Sci/R&D Officer at SANOFI
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kate Bingham | F | 58 |
Cybele Therapeutics Ltd.
 Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom.
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer.
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest.
Zarodex Therapeutics Ltd.
 Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom.
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 19 years |
| Emma Tinsley | F | - |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017.
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 9 years |
| Duncan McHale | M | 57 |
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | 7 years |
| Frédéric Oudéa | M | 60 | 2 years | |
| Madeleine Roach | F | 40 | 2 years | |
| Charles Dunn | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Alexandra Roger | F | - | 8 years | |
| Anne Prener | M | 66 |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom.
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Barbara Lavernos | F | 56 | 3 years | |
| Paul Hudson | M | 56 | 5 years | |
| Fabienne Lecorvaisier | F | 61 | 11 years | |
| Rachel Duan | F | 52 | 4 years | |
| Nestle Frank | M | - | 8 years | |
| Antoine Yver | M | 66 | 2 years | |
| Ailsa Helen Louise Craig | F | 47 |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | 18 years |
| Emile Voest | M | 64 | 2 years | |
| Emmanuel Frenehard | M | 51 | - | |
| Gilles Schnepp | M | 64 | 4 years | |
| Lise Kingo | F | 62 | 4 years | |
| Arnaud Delépine | M | - | - | |
| Patrick Kron | M | 70 | 10 years | |
| Carole Ferrand | F | 53 | 2 years | |
| Anuj Madhok | M | 49 |
Zarodex Therapeutics Ltd.
Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | - |
| Duncan Philip McHale | M | 58 |
Zarodex Therapeutics Ltd.
Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | 7 years |
| Alexander Robert Leech | M | 52 |
Zarodex Therapeutics Ltd.
Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | - |
| Joanna Wolak | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Mike Ross | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 22 years |
| Brendan OCallaghan | M | 62 | 9 years | |
| Julie van Ongevalle | F | 49 | 4 years | |
| Wolfgang Laux | M | 56 | 3 years | |
| Iain Kilty | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 2 years |
| Tetsu Maruyama | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 1 years |
| Georgia Frost | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 2 years |
| Georgina Ewels | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Raj Verma | M | - | 4 years | |
| Sally Bain | F | - | - | |
| Yann Tran | M | 58 | 3 years | |
| Kate Bingham | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 33 years |
| Josep Catlla | M | - | - | |
| Michael Heneka | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Tom Patton | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Dirk Landgraf | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Damian Crowther | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| William Gerard | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 3 years |
| David Reynolds | M | 51 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Michael Ross | M | 75 |
Cellinta Ltd.
Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom. | - |
| Rebecca Canter | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 6 years |
| Olivier Antoine M. Charmeil | M | 59 | 18 years | |
| Graham J. Boulnois | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 23 years |
| Kevin Pojasek | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 6 years |
| Allan W. May | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Stephen Davies | M | 74 |
University of Oxford
| 28 years |
| Lionel Tarassenko | M | 67 |
University of Oxford
| 27 years |
| Hamish Alan Cameron | M | 70 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 16 years |
| Jonathan Behr | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | - |
| Aaron Sandoski | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Natalie Bickford | F | 53 | 4 years | |
| Ryan Pierce | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 4 years |
| Felix Lauscher | M | - | - | |
| Laurence Barker | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 8 years |
| Barbara Tate | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 8 years |
| Roy Papatheodorou | M | 46 | 2 years | |
| Sandrine Guendoul | F | - | - | |
| Christian Billy Jung | M | 42 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 5 years |
| Dietmar Berger | M | - | 5 years | |
| Brett K. Haumann | M | 54 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 1 years |
| Lars Henrik Fugger | M | 64 |
University of Oxford
| 17 years |
| Ruth McKernan | M | 66 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 6 years |
| Christophe Babule | M | 58 | 5 years | |
| Freya Easton | F | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 2 years |
| Kevin Robert Pojasek | M | 48 |
Ervaxx Ltd.
Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | - |
| James Allister John Costine | M | 42 |
Cybele Therapeutics Ltd.
Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Denise Marks | F | - |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | 16 years |
| William Guilherme Doo | M | 51 |
University of Oxford
| 6 years |
| emma chandra | F | - |
University of Oxford
| 3 years |
| Chad Frischmann | M | - |
University of Oxford
| 5 years |
| Simon Wolfgang Hartmut Goeller | M | 44 |
University of Oxford
| 5 years |
| de Vere Max | M | - |
University of Oxford
| 4 years |
| Kieran Mahanty | M | - |
University of Oxford
| 5 years |
| Alex Hood | M | - |
University of Oxford
| 4 years |
| Matthew Powell | M | - |
University of Oxford
| 5 years |
| Elwyn Davies | M | - |
University of Oxford
| 3 years |
| John Lee Allen | M | - |
University of Oxford
| 15 years |
| Truman Packard | M | - |
University of Oxford
| 7 years |
| Hong Jun Zhong | M | 53 |
University of Oxford
| 3 years |
| Kathryn Farrar | F | 47 |
University of Oxford
| 5 years |
| Diane D. Souza | F | 71 | 8 years | |
| Akhil Paul | M | 39 |
University of Oxford
| 4 years |
| Gao Meng | F | 43 |
University of Oxford
| 5 years |
| Philip Hodges | M | - |
University of Oxford
| 7 years |
| David John Rawlins | M | 43 |
University of Oxford
| 3 years |
| Thomas C. Südhof | M | 68 | 8 years | |
| Nigel L. Clarke | M | - |
University of Oxford
| 4 years |
| Rachel Webster | M | - |
University of Oxford
| 5 years |
| Rayhan Davis | M | 45 |
University of Oxford
| 4 years |
| Mark Carney | M | 59 |
University of Oxford
| 3 years |
| Philip Shapiro | M | 49 |
University of Oxford
| 3 years |
| William Ashby | M | - |
University of Oxford
| 4 years |
| Sam Blake | M | - |
University of Oxford
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 39 | 39.39% |
| France | 32 | 32.32% |
| United States | 31 | 31.31% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Houman Ashrafian
- Personal Network